NCT04436133 2022-05-06Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)National Vaccine and Serum Institute, ChinaPhase 2 Completed480 enrolled